524400 Stock Overview
Manufactures and sells active pharma ingredients (APIs), fine chemicals, drug intermediates, and excipients in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Ishita Drugs and Industries Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹71.86 |
| 52 Week High | ₹104.75 |
| 52 Week Low | ₹56.00 |
| Beta | 0.28 |
| 11 Month Change | -8.17% |
| 3 Month Change | -13.24% |
| 1 Year Change | -0.21% |
| 33 Year Change | 79.87% |
| 5 Year Change | 474.88% |
| Change since IPO | 736.55% |
Recent News & Updates
Recent updates
Shareholder Returns
| 524400 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 0.2% | -0.2% | 0.3% |
| 1Y | -0.2% | 40.5% | 27.3% |
Return vs Industry: 524400 underperformed the Indian Pharmaceuticals industry which returned 40.5% over the past year.
Return vs Market: 524400 underperformed the Indian Market which returned 27.3% over the past year.
Price Volatility
| 524400 volatility | |
|---|---|
| 524400 Average Weekly Movement | 5.6% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.2% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 524400 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 524400's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | 17 | Jagdishprasad Agrawal | www.ishitadrugs.com |
Ishita Drugs and Industries Limited manufactures and sells active pharma ingredients (APIs), fine chemicals, drug intermediates, and excipients in India and internationally. The company offers APIs, such as sulfa drugs/sulfonamides, vitamins, fluoro quinolones, antibiotics, anthelmintics, iodides and citrates, food additives/excipients, and others. It provides contract manufacturing services for various drug intermediates, fine chemicals, or specialty chemicals.
Ishita Drugs and Industries Limited Fundamentals Summary
| 524400 fundamental statistics | |
|---|---|
| Market cap | ₹214.88m |
| Earnings (TTM) | ₹7.43m |
| Revenue (TTM) | ₹140.08m |
28.9x
P/E Ratio1.5x
P/S RatioIs 524400 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 524400 income statement (TTM) | |
|---|---|
| Revenue | ₹140.08m |
| Cost of Revenue | ₹118.36m |
| Gross Profit | ₹21.72m |
| Other Expenses | ₹14.29m |
| Earnings | ₹7.43m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.49 |
| Gross Margin | 15.51% |
| Net Profit Margin | 5.31% |
| Debt/Equity Ratio | 20.6% |
How did 524400 perform over the long term?
See historical performance and comparison